These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3907969)
1. Effect of norethisterone enanthate on the blood count and endometrial histology of Indian women. Chaudhuri C; Dutta SK; Mukherjea M Contraception; 1985 Oct; 32(4):417-28. PubMed ID: 3907969 [TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756 [TBL] [Abstract][Full Text] [Related]
3. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women. Meng YX; Virutamasen P Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702 [TBL] [Abstract][Full Text] [Related]
4. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns. McEwan JA; Griffin M Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620 [TBL] [Abstract][Full Text] [Related]
5. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
6. Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus. Achari K J Obstet Gynaecol India; 1969; 19(6):731-6. PubMed ID: 12255497 [TBL] [Abstract][Full Text] [Related]
7. Phase IV study of the injection Norigest in Pakistan. Kazi A; Holck SE; Diethelm P Contraception; 1985 Oct; 32(4):395-403. PubMed ID: 3907968 [TBL] [Abstract][Full Text] [Related]
8. A clinical trial of norethisterone oenanthate (Norigest) injected every two months. Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569 [TBL] [Abstract][Full Text] [Related]
9. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility. Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593 [TBL] [Abstract][Full Text] [Related]
10. Acceptability of injectable contraceptives in Assiut, Egypt. Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583 [TBL] [Abstract][Full Text] [Related]
11. Hemostatic changes in women using a monthly injectable contraceptive for one year. Meng YX; Jiang HY; Chen AJ; Lu FY; Yang H; Zhang MY; Shen KY; Sun DL; Shao QX; Fotherby K Contraception; 1990 Oct; 42(4):455-66. PubMed ID: 2124180 [TBL] [Abstract][Full Text] [Related]
12. Effect of switching with oral contraceptives. Wassef SA; Sami G; Hamid EA Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511 [TBL] [Abstract][Full Text] [Related]
13. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities. Zaki K; Kamal I; Talaat MM; Rashad S; Nour H Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027 [TBL] [Abstract][Full Text] [Related]
14. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration. Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955 [TBL] [Abstract][Full Text] [Related]
15. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
16. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility. Gray RH; Parker RA; Diethelm P Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters. Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019 [TBL] [Abstract][Full Text] [Related]
18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]
19. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile. Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754 [TBL] [Abstract][Full Text] [Related]